Product image of Olartan-Plus (Olmesartan Medoxomil, Hydrochlorothiazide) supplied by GNH India

Olartan-Plus

Active Ingredient:
Olmesartan Medoxomil, Hydrochlorothiazide
Origin:
EU

Olartan-Plus (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan Medoxomil, the active ingredient in Olartan-Plus, is a Angiotensin II receptor blocker (ARB) presented as an oral tablet for oral use. It treats hypertension in adult patients and helps lower cardiovascular risk.

GNH India supplies Olartan-Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Menarini International Operations Luxembourg S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Olartan-Plus, an ARB‑thiazide combination, is used to manage elevated blood pressure within the hypertension therapeutic area.

  • Hypertension: reduces systolic and diastolic blood pressure, improving overall cardiovascular control.

How It Works

  • Olmesartan medoxomil selectively blocks AT1 receptors, preventing angiotensin II from causing vasoconstriction and aldosterone release. Hydrochlorothiazide acts on the distal convoluted tubule to inhibit NaCl reabsorption, increasing urinary excretion of sodium and water, thereby lowering plasma volume and blood pressure.

Side Effects

Adverse reactions may occur with Olartan-Plus and are categorized by frequency.

Common Side Effects

  • Dizziness or light‑headedness
  • Headache
  • Fatigue
  • Increased urination
  • Electrolyte disturbances (e.g., low potassium)
  • Mild gastrointestinal upset

Serious or Rare Side Effects

  • Severe hypotension
  • Acute kidney injury
  • Hyperkalemia
  • Angioedema
  • Severe electrolyte imbalance (e.g., hyponatremia)
  • Allergic skin reactions (e.g., rash, Stevens‑Johnson syndrome)

Precautions & Warnings

Patients should be aware of specific safety considerations before using Olartan-Plus.

  • Pregnancy: contraindicated in pregnancy (Category D) due to risk of fetal toxicity.
  • Renal impairment: monitor kidney function and adjust therapy as needed.
  • Electrolyte balance: check serum potassium and sodium regularly.
  • Concomitant diuretics: assess for additive hypotensive effects.
  • Gout: may increase serum uric acid; monitor in susceptible individuals.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and light.

Avoid Interactions

Olartan-Plus may interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, other ARBs) – risk of severe hypotension and renal failure.
  • Potassium‑sparing diuretics or supplements – risk of hyperkalemia.
  • Lithium – increased lithium levels, potential toxicity.

Moderate Interactions (Monitor Closely)

  • NSAIDs – may reduce antihypertensive effect and impair renal function.
  • Antidiabetic agents – may enhance hypoglycemic effect.
  • CYP450 inhibitors (e.g., ketoconazole) – may increase olmesartan levels.
  • Loop diuretics – additive diuretic effect, monitor electrolytes.

Frequently Asked Questions

Olartan-Plus is prescribed to lower high blood pressure (hypertension) in adult patients. By combining an angiotensin II receptor blocker with a thiazide diuretic, it helps achieve better blood pressure control and reduces cardiovascular risk.

Olmesartan Medoxomil blocks AT1 receptors, preventing angiotensin II from causing vasoconstriction and aldosterone release. This leads to relaxed blood vessels and reduced fluid retention, contributing to lower blood pressure.

The dosage of Olartan-Plus is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and other individual factors. No fixed dose is provided here.

Olartan-Plus is classified as Pregnancy Category D, indicating potential risk to the fetus and should be avoided during pregnancy. Safety during breastfeeding has not been established, so use is generally not recommended.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Olartan-Plus combines an ARB with a thiazide diuretic, offering dual mechanisms that can provide more effective blood pressure reduction than monotherapy with either class alone. It is often preferred when a single‑pill regimen is desired for better adherence.

Olartan-Plus tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect them from moisture, excessive heat, and direct sunlight to maintain product stability.

Olartan-Plus is taken orally, usually once daily, with or without food, as directed by the healthcare professional. Swallow the tablet whole with a glass of water.

Serious risks include severe hypotension, acute kidney injury, hyperkalemia, and angioedema. Patients should be monitored for signs of these conditions, especially when initiating therapy or adjusting doses.

Olartan-Plus should not be used by individuals with known hypersensitivity to olmesartan, hydrochlorothiazide, or any component of the formulation, as well as pregnant women. Caution is also advised for patients with severe renal impairment or electrolyte disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.